Insufficient scRNA-seq data for expression of CLDN9 at single-cell level.
Insufficient scRNA-seq data for expression of CLDN9 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 100% | 346.44 | 328 / 328 | 78% | 12.38 | 139 / 178 |
liver | 93% | 244.42 | 210 / 226 | 42% | 8.25 | 171 / 406 |
lung | 92% | 121.02 | 531 / 578 | 41% | 9.00 | 478 / 1155 |
brain | 97% | 557.79 | 2562 / 2642 | 20% | 0.88 | 138 / 705 |
thymus | 34% | 30.36 | 221 / 653 | 80% | 24.65 | 486 / 605 |
ureter | 0% | 0 | 0 / 0 | 100% | 28.89 | 1 / 1 |
spleen | 98% | 215.37 | 236 / 241 | 0% | 0 | 0 / 0 |
ovary | 1% | 0.33 | 1 / 180 | 90% | 39.65 | 388 / 430 |
peripheral blood | 80% | 925.16 | 744 / 929 | 0% | 0 | 0 / 0 |
stomach | 42% | 27.38 | 150 / 359 | 38% | 3.99 | 108 / 286 |
intestine | 38% | 27.89 | 369 / 966 | 36% | 4.29 | 192 / 527 |
muscle | 60% | 58.69 | 482 / 803 | 0% | 0 | 0 / 0 |
adrenal gland | 13% | 12.25 | 34 / 258 | 46% | 3.99 | 106 / 230 |
heart | 52% | 53.46 | 449 / 861 | 0% | 0 | 0 / 0 |
bladder | 14% | 15.24 | 3 / 21 | 38% | 8.37 | 190 / 504 |
kidney | 37% | 35.24 | 33 / 89 | 11% | 0.82 | 95 / 901 |
uterus | 8% | 8.97 | 14 / 170 | 37% | 10.31 | 170 / 459 |
esophagus | 16% | 10.95 | 224 / 1445 | 25% | 3.47 | 46 / 183 |
breast | 19% | 11.09 | 86 / 459 | 21% | 2.58 | 234 / 1118 |
prostate | 32% | 21.67 | 78 / 245 | 3% | 0.13 | 14 / 502 |
adipose | 27% | 17.71 | 322 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 13% | 0.63 | 6 / 45 |
skin | 8% | 4.18 | 141 / 1809 | 3% | 0.12 | 14 / 472 |
blood vessel | 3% | 1.85 | 39 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0046718 | Biological process | symbiont entry into host cell |
GO_0016338 | Biological process | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules |
GO_0007155 | Biological process | cell adhesion |
GO_0070830 | Biological process | bicellular tight junction assembly |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0030054 | Cellular component | cell junction |
GO_0005886 | Cellular component | plasma membrane |
GO_0005923 | Cellular component | bicellular tight junction |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
GO_0001618 | Molecular function | virus receptor activity |
GO_0005198 | Molecular function | structural molecule activity |
Gene name | CLDN9 |
Protein name | Claudin-9 |
Synonyms | |
Description | FUNCTION: Plays a major role in tight junction-specific obliteration of the intercellular space, through calcium-independent cell-adhesion activity. .; FUNCTION: (Microbial infection) Acts as a receptor for hepatitis C virus (HCV) entry into hepatic cells. . |
Accessions | O95484 ENST00000445369.3 |